Cargando…

High body mass index is not associated with increased treatment failure in infliximab treated pediatric patients with inflammatory bowel disease

BACKGROUND AND AIM: While weight gain during infliximab therapy in inflammatory bowel disease (IBD) is common, there has been limited research evaluating its impact on infliximab efficacy. METHODS: Primary aims of this study were to determine the frequency of excess weight gain (body mass index [BMI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodin, Isaac, Chan, Justin, Meleady, Laura, Hii, Clare, Lawrence, Sally, Jacobson, Kevan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Publishing Asia Pty Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273726/ https://www.ncbi.nlm.nih.gov/pubmed/32514452 http://dx.doi.org/10.1002/jgh3.12277

Ejemplares similares

Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review
por: Lawrence, Sally J., et al.
Publicado: (2017)

Body mass index influences the response to infliximab in ankylosing spondylitis
por: Ottaviani, Sébastien, et al.
Publicado: (2012)

Early Serum Infliximab Levels in Pediatric Ulcerative Colitis
por: deBruyn, Jennifer C. C., et al.
Publicado: (2021)

Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease
por: Michaux, Mielle, et al.
Publicado: (2023)

Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab
por: Scaldaferri, Franco, et al.
Publicado: (2017)

Efficacy of Infliximab Biosimilar for Maintenance Therapy in Pediatric Inflammatory Bowel Disease Following Infliximab Originator
por: Hinshaw, Amie, et al.
Publicado: (2022)

Body mass index and survival in people with heart failure
por: Jones, Nicholas R, et al.
Publicado: (2023)

A45 INFLIXIMAB IN COMBINATION WITH AN IMMUNOMODULATOR IS ASSOCIATED WITH AN ATTENUATED ANTIBODY RESPONSE TO BNT162B2 SARS-COV-2 VACCINE IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
por: Lawrence, S, et al.
Publicado: (2022)

Infliximab in inflammatory bowel disease
por: Papamichael, Konstantinos, et al.
Publicado: (2019)

Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood
por: Eindor-Abarbanel, Adi, et al.
Publicado: (2021)

Comparing Health Administrative and Clinical Registry Data: Trends in Incidence and Prevalence of Pediatric Inflammatory Bowel Disease in British Columbia
por: Chan, Justin M, et al.
Publicado: (2021)

Body Mass Index at Presentation of Inflammatory Bowel Disease in Children
por: Medina Carbonell, Fernando R, et al.
Publicado: (2020)

Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease
por: Hellmann, Jennifer, et al.
Publicado: (2021)

Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease
por: Kolho, Kaija-Leena
Publicado: (2021)

Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?
por: Healey, Genelle R., et al.
Publicado: (2020)

Inflammatory bowel disease of the lung: The role of infliximab?()
por: Hayek, Adam J., et al.
Publicado: (2015)

Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximab
por: Burkard, Theresa, et al.
Publicado: (2023)

A28 RESPONSE RATE OF VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PATIENTS TO ANTI-TNF TREATMENT IS HIGHER THAN PREVIOUSLY REPORTED, BUT HIGHER DOSING IS REQUIRED-A LARGE TERTIARY SINGLE CENTER EXPERIENCE
por: Eindor, A, et al.
Publicado: (2022)

Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease
por: Choi, So Yoon, et al.
Publicado: (2017)

Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease
por: Choi, So Yoon, et al.
Publicado: (2019)

Management of inflammatory bowel disease in poor responders to infliximab
por: Guerra, Iván, et al.
Publicado: (2014)

Tri-ponderal mass index and body mass index in prediction of pediatric metabolic syndrome: the CASPIAN-V study
por: Khoshhali, Mehri, et al.
Publicado: (2020)

Changing Incidence of Inflammatory Bowel Disease: Environmental Influences and Lessons Learnt from the South Asian Population
por: Foster, Alice, et al.
Publicado: (2013)

A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia
por: Paviglianiti, Annalisa
Publicado: (2020)

Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease
por: Curci, Debora, et al.
Publicado: (2022)

Dapagliflozin for heart failure according to body mass index: the DELIVER trial( )
por: Adamson, Carly, et al.
Publicado: (2022)

Pediatric Quality of Life Inventory(TM) version 4.0 short form generic core scale across pediatric populations review data
por: Smyth, Matthew, et al.
Publicado: (2021)

Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab
por: Puthoor, Pamela R., et al.
Publicado: (2013)

Pediatric Gastrointestinal Sarcoidosis: Successful Treatment with Infliximab
por: Alawdah, Laila, et al.
Publicado: (2016)

Profile of infliximab in the treatment of pediatric Crohn’s disease
por: Kierkus, Jaroslaw, et al.
Publicado: (2015)

Failure of Isoniazid Chemoprophylaxis during Infliximab Therapy
por: Fernández-Guerrero, Manuel L., et al.
Publicado: (2007)

The Association between Body Mass Index and Mortality in Incident Dialysis Patients
por: Badve, Sunil V., et al.
Publicado: (2014)

Retrospective Cohort Study Comparing Infliximab-dyyb and Infliximab in Biologic-Naive Patients With Inflammatory Bowel Disease in the United States
por: Smith, Joshua T, et al.
Publicado: (2021)

Body Mass Index Is Associated with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
por: Dong, Jie, et al.
Publicado: (2015)

Modeling Pediatric Body Mass Index and Neighborhood Environment at Different Spatial Scales
por: Grant, Lauren P., et al.
Publicado: (2018)

Impact of body mass index on surgical coronary revascularization for ischaemic heart failure: insights from STICHES
por: Hendren, Nicholas S., et al.
Publicado: (2020)

The Relationship of Chronic Renal Failure and Body Mass Index in Patients without Diabetes
por: Kristic, Spomenka, et al.
Publicado: (2013)

Association between body mass index and prognosis of patients hospitalized with heart failure
por: Seko, Yuta, et al.
Publicado: (2020)

Relationship between body mass index, cardiovascular biomarkers and incident heart failure
por: Suthahar, Navin, et al.
Publicado: (2021)

Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure
por: Ye, Li-fang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bt6uetgr627kuichvctocikcgv